Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 1, 2014
Event Date: March 31, 2014
Context: The registrant entered into a material definitive agreement to amend its existing accounts receivable securitization program (the "Receivables Facility").
Key Financial Metrics
This filing reports on a specific financing transaction rather than periodic operating results. Consequently, revenue, profit, cash flow, and margin data are not provided in this document.
- Facility Size Increase: The Receivables Facility capacity was increased from $500 million to $700 million.
- Facility Termination Date: Extended to March 21, 2016.
- Lenders: Includes Credit Agricole Corporate and Investment Bank (Administrative Agent), The Bank of Nova Scotia, and The Bank of Tokyo-Mitsubishi UFJ, Ltd.
- Collateral: Health care accounts receivable (excluding self-pay) originated by CHS subsidiaries.
Material Changes Versus Prior Period
The primary material change is the expansion of the company's liquidity facility:
- Capacity Expansion: Borrowing availability increased by $200 million (from $500 million to $700 million).
- Term Extension: The scheduled termination date of the facility was extended.
- Structural Amendments: The Receivables Sale Agreement, Receivables Purchase and Contribution Agreement, and Receivables Loan Agreement were amended via a Third Omnibus Amendment.
Guidance, Outlook, Risks, and Contingencies
Management Commentary: The filing details the mechanics of the "true sale" of receivables to a bankruptcy-remote special purpose entity (CHS Receivables Funding, LLC) to secure borrowings. Funding is provided via asset-backed commercial paper or a committed liquidity facility.
Risks and Contingencies:
- Termination Events: The facility may be terminated early due to failure to make timely payments, breach of covenants, failure to meet leverage or Receivables ratios, or certain changes of control.
- Guarantees: CHS guarantees the performance of the Collection Agent but explicitly does not guarantee the collection of receivables if the obligor becomes insolvent or bankrupt.
- Fees: The company is obligated to pay upfront fees to managing agents and ongoing usage fees to lenders.
Important Facts for Investor Verification
- Verify the impact of the $200 million facility expansion on the company's total debt load and leverage ratios in subsequent 10-Q or 10-K filings.
- Confirm the specific interest rates and fee structures associated with the amended facility, as exact percentages are not listed in this summary.
- Monitor compliance with the new leverage and Receivables ratios to avoid early termination of the facility.
- Review the full text of the Third Omnibus Amendment (Exhibit 10.1) for detailed covenant requirements.